semaglutide lactation IABLE Semaglutide and Breastfeeding – Breastfeeding

Baseline labs (creatinine, eGFR, urinalysis) are essential, followed by repeat labs every 48 weeks during the first 3 months, then every 36 months once stable

Before considering any off-label combination approach, a comprehensive evaluation including genetic predisposition screening and biomarker assessment can help providers and patients optimize single-agent therapy

While tirzepatide carries an established safety profile from large randomized trials, the combination with HCG remains outside mainstream clinical consensus and requires careful monitoring of appetite, weight trajectory, metabolic labs, and any adverse effects

Ready to stop looking for shortcuts

Erectile Effects of Other Antidiabetic Therapies: Mechanistic Insights and Clinical Evidence Multiple studies have examined the effects of antidiabetic therapies on erectile function, but findings remain inconsistent and at times contradictory

Week 1-2: Foundations Calculate and track protein intake